Company Summary

Business Purpose

• A blank check exempted company incorporated in the Cayman Islands on January 18, 2024.
• Purpose: Enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.

Industry and Geographic Focus

• No specific industry or geographic restriction.
• Will evaluate target companies across various industries and locations.
• Significant ties to China, considering potential business combinations with Chinese companies, especially those in China or operating under the VIE structure.

Capital Raising

• Conducted an Initial Public Offering (IPO) on January 24, 2025:
  • Sold 6,000,000 units at $10.00 each, grossing $60,000,000.
  • Each Unit includes:
    • One ordinary share (par value $0.0001).
    • One right to receive one-seventh of an ordinary share after completion of the business combination.
• Private Placement:
  • 234,290 private units sold to sponsor for $10.00 each, totaling $2,342,900.
  • Proceeds placed in a Trust Account for the benefit of shareholders.
• Represenative Shares: 210,000 shared issued to underwriters, held under restrictions.

Business Status

• No revenue generated to date.
• Has incurred losses since inception due to formation and operating costs.
• Funded operations primarily through securities sales and loans from sponsor.
• As of the report date:
  • No specific target identified or selected.
  • Focused on identifying and evaluating acquisition candidates.

Management & Shareholder Details

• As of the report date:
  • Insiders, including sponsor, officers, and directors, hold 21.83% of outstanding shares.
  • Sponsor forfeited 225,000 founder shares in March 2025; now holds about 1,698,290 shares, including founder shares and private units.
• Officers:
  • Dr. Fen “Eric” Zhang (CEO, resides in China, Canadian citizen)
  • Ms. Jie “Janet” Hu (CFO, located in China)
  • Mr. Cameron R. Johnson (Director, appointed in March 2025)

Trading and Listing

• Shares and Rights began trading on Nasdaq on March 17, 2025:
  • Shares traded under symbol “COLA”.
  • Rights traded under symbol “COLAR”.
  • Public units continue trading under “COLAU”.
• No revenue or assets in China or from China-based operations currently.

Strategy & Evaluation Criteria

• Focuses on acquiring emerging growth companies with:
  • Niche deal size suitable for generating or already generating cash.
  • Industry leadership with competitive advantages.
  • Long-term revenue visibility and defensible market positions.
  • Benefits from being a U.S. public company (value, marketing).
  • Financial metrics: organic growth, cost savings, accelerated growth, value creation potential.
• May deviate from guidelines if deemed appropriate.
• Will seek shareholder approval or tender offers for business combinations.

Regulatory & Risk Factors

• Significant focus on regulatory risks related to Chinese laws, VIE structures, cybersecurity, and foreign ownership restrictions.
• Will comply with U.S. and Chinese regulations if acquiring Chinese targets.
• No current plan for specific targets; efforts concentrated on screening and evaluating potential targets.

Office & Employees

• Located at 14 Prudential Tower, Singapore.
• Paying $10,000/month for office, utilities, and support since January 22, 2025.
• Currently has two officers:
  • CEO (Dr. Zhang)
  • CFO (Ms. Hu)
• No full-time employees prior to completing a business combination.

Revenue & Income

• No revenue reported.
• Losses incurred since inception, due to formation and operation costs.
• No assets or revenue generated from Chinese operations or elsewhere.

Note: The company’s primary activity has been fundraising and evaluating business combination opportunities; no specific business operations or revenues are reported as of the date.